Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Hacking Your ADHD

Research Recap with Skye: Effectiveness of Microdosing on ADHD

Nov 6, 202618 minVideo
ShareXLinkedInFacebookWhatsAppEmail

Welcome to Hacking Your ADHD. I'm your host, William Curb, and I have ADHD. On this podcast, I dig into the tools, tactics, and best practices to help you work with your ADHD brain. Today, I'm joined by Skye Waterson for our Research Recap series. In this series, we take a look at a single research paper and dive into what the paper says, how it was conducted, and try and find any practical takeaways. In this episode, we're going to be discussing a paper calle d "Effects of Psychedelic Microdosing versus Conventional ADHD Medication Use on Emotional Regulation, Empathy, and ADHD Symptoms in Adults with Severe ADHD Symptoms: A Naturalistic Prospective Comparison Study." That is a mouthful. If you'd life to follow along on the show notes page you can find that at HackingYourADHD.com/322 https://tinyurl.com/56rvt9fr - Unconventional Organisation Affiliate link https://tinyurl.com/y835cnrk - YouTube

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show.

0:04Welcome to Hacking Your ADHD. I'm your host, William Curb, and I have ADHD. On this podcast, I dig into the tools, tactics, and best practices to help you work with your ADHD brain. Today, I'm joined by Skye Waterson for our Research Recap series. In this series, we take a look at a single research paper and dive into what the paper says, how it was conducted, and try and find any practical takeaways. In this episode, we're going to be discussing a paper called "Effects of Psychedelic Microdosing versus Conventional ADHD Medication Use on Emotional Regulation, Empathy, and ADHD Symptoms in Adults with Severe ADHD

0:38Symptoms: "A Naturalistic Perspective Comparison Study." That is a mouthful. And yeah, that's right, we're going to be talking about psychedelics today. So before we dive in, a few things to flag. I am not, a doctor. Skye, are you a doctor? not So keep that in mind while you are listening. This episode isn't medical, psychiatric, or legal advice. We'll be discussing psychedelics, microdosing, and some published research on ADHD and mental health, but research findings, and especially

1:08early uncontrolled studies like some of the ones we're covering today, are not the same as clinical guidance for any individual person. These substances remain illegal in many jurisdictions, and use carries real legal risk that varies by where you live. They can also interact seriously with certain psychiatric medications and mental health conditions. So if that applies to you, this is a conversation that you should be having with your doctor and not something that you're basing off of a podcast. Take everything here as informational and not instructional.

1:40And yes, that all sounds very serious, but, I think it's worth, saying before we get into this Yeah, 100%, 100%. And the you know, qualitative researcher in me also wants to mention our own experiences. We're not talking about our own experiences. This is not a way to describe our own experiences with psychedelics, which are effectively, at least for me, they don't exist. So it's, this is, the perspective that I'm bringing to this, to this paper as well

2:11Yeah, I was, looking through like the questionnaire here where it's like, what have you experienced with, ash-- I don't even know how to say that. DMT, 5-MeO-DMT, LSD, just a list of these things that I'm like, "Oh, I've heard of some of those," and many I have not. so yeah, this is not an area that I'm very experienced in, so let's always take that with a grain of salt while you're listening to this, 'cause can only bring our own experience to this, and really we're mostly just trying to

2:42look at what the research says, not what our experience with or lack thereof. Yeah, 100%. So this paper is from 2024. There are other papers that go up to 2026 where they have done larger studies of studies on psychedelics, 'cause believe it or not, this has been studied quite a few times, that have not found significant results. so this was, when we were looking at it at least, this was the kind of most up-to-date version that found a significant result.

3:13and that's why we're talking about it. but yeah, I just wanna keep that in mind. There was later research where they found no significance. They were doing this, systematic reviews. But it's not a really fun, it's not a really fun conversation to be like, "And then they w- didn't find anything," so we, like everybody, have a bit of a publication bias when it comes to that. Yeah. although I'm sure we'll find some stuff where we're like, "Hey, this is something that a lot of people are talking about and it's not true." Yeah, I think we have done that actually Yeah.

3:44so really interesting about this paper is it's actually looking at two studies they did, 'cause they did a first study, and then they were like, "Okay, we need to, for final results," because the control on the first one was nonexistent. and that did have an effect on the results they Yeah. I did find it really interesting they included the second study. The, sorry, the first study because sometimes, people just won't. I also found it interesting they didn't have a control group in general. But yeah, they, with this first study, this one was, looking at, It was a pers-

4:22online prospective naturalistic study. So they were finding people, recruiting them online, people who had the intention to microdose on their own initiative, and, it had no experimental manipulations. It just collected data during participants' self-initiated microdosing practices. So in some ways, I imagine this was potentially a study that they did just to see the, see what, what was even out there in terms of microdosing

4:53Yeah, because it's something that I see a lot of talk about online, but, There is so much that their people are just like, "Oh yeah, this is how this works." And it's okay, but what's act- what are the mechanisms underneath? What are people actually doing? Should we even be doing more research with it? And I think that was really the point of their first study. Yeah, 100%. So they had, people who were diagnosed with ADHD and those

5:23who didn't have a diagnosis but experienced severe symptoms, which, to be fair, a lot of papers do that. They actually also, had a, people who didn't have a d- diagnosis and they had T-scores which were too low on a general, ADHD symptom scale, were not included. So they did have a cutoff, which I thought was interesting, 'cause I actually, haven't seen that ex- explicitly stated in other papers

5:55Yeah, and I guess it's worth also, that it's, a responsible thing to do in this research for them because I'm sure m- people with more extreme symptoms are more likely to be reaching out for these substances. And if we wanna have a better sense of if they're working or not, you wanna kinda have more of the mean of what people are at rather than on either the extreme end of, the findings here. 'Cause you're gonna be-- Most people that have low symptoms are not

6:26going to be trying to reach out for microdosing 'cause that's, a more, I don't know. I, personally, I would not, that would be not be my first, go-to. Yeah. I, do, I know people who wouldn't agree with you there, so I do feel like That is true. Yeah but yeah, so they, in terms of the diagnosis questionnaire, they did the CARS SSV, assessed sy- ADHD symptom severity, symptom severity.

6:58They also did an emotional regulation questionnaire, as well as, looking at, empathy and, and that was kinda their focus. They wanted to look at emotional regulation specifically Yeah, which is, also I think an, interesting thing to choose to look for because most ADHD medication is not focused on the emotional regulation side of things because that's not a priority in the medical field.

7:28Yeah. And they pointed that, pointed to that as a reason to do this study in the first place. I think anybody who prescribes SSRIs is probably, waving their hand like, "Hello. We do some stuff." but in terms of specifically ADHD medication, yeah, there is a gap Yeah. Yeah, and yeah, they were looking, definitely at, the ability for people to take, different people's perspectives, their empathetic concerns, and, this…

8:02One of the interesting things that like they had the, like the fantasy rating, and I was like, "What is that?" It's basically the same thing as empathy, but with like fictional characters where you can put yourself in someone else's shoes kind of thing. and then also this, layer of like personal distress, and how you're feeling about yourself. Yeah, exactly. So in terms of the results that they found with that, they did find results.

8:33but like they said, they were… There's no control group, so this is more of just a naturalistic study, rather than something you could do, you know, significance with in any real way Yeah. And I guess another thing to-- with the naturalistic study to note is the, what was-- what people were taking was less standardized than you would have in a, like a randomized control study or something.

9:06Yes. yeah. They had a whole list of different things that people were taking, like, you said, ayahuasca, LSD, psilocybin, mushrooms, truffles, things like that Yeah. And I, me, I even saw the note that like, they're like, "But even with that, we weren't controlling for if the mushrooms were dried or not." And I'm like, "That must have some effect, and I don't know which way it goes." yeah, 100%. and I am curious, they didn't really talk about it here, that I saw, so I'm curious on your take.

9:38I'm ass- like, when I've seen these studies done before, they're done with a, like a, a university group that has access to a specific kind of, you know, mushroom, LSD medication, and is microdosing it for the participant, versus this one which felt very much like this isn't legal, but we're asking you to tell us about it anyway. Yeah. Yeah

10:09And yeah, they did not have the best, attrition rate. it was fine, but it was, just you had, quite a few people drop out over the course. I'm missing my numbers here. I thought I put them right here, but I didn't. but it is something like, to note that, yeah, with that attrition rate, you do see people that are like, that would have seen a positive result

10:41staying in the study longer because they're getting their own medication. Yeah. Yeah, exactly. Exactly. And yeah, so we move on to study two, where they include, included a, control group and an ADHD system, symptom severity measure for a more comprehensive understanding of the effects. So clearly they took this study, I don't know if this for sure, but usually what happens is they'll take it to somebody, they'll show it to a professor or somebody, a mentor, and that person will say, "Look, this is great, but

11:14you're not gonna publish this as is. You're gonna n- need to go and do a second study." And that's exactly what they did Yeah. And they did see a reduction in most of the results, from the first study, which with the exception of, percep- perspective taking, which had higher throughput, but it was-- took longer for that to take effect. So it's interesting to be like, "Oh yeah, that one outside

11:46effect was actually greater. that's weird." but yeah. And so it is a thing where, yeah, with-- We saw, the microdosing saw a, reduction compared to the, I always forget what tau as usual. Yeah, so for study two they had, they had baseline measurements, two week,

12:17four week, and they were, yeah, like they said, they had a control group. Yeah. So it was like, yeah, they had-- To get their, my numbers right. Started with 50, in the microdosing group, started with 37 in the tau group. And then, the attrition rate at the end, they had 38 in the, microdosing group and 28 in the Yeah. And they were really careful. If somebody used a psychedelic substance during the study and they weren't in

12:48the group, then they were not included. So they were looking for… You had to only use medication in one group and only use psychedelics in, the other group. and they, that's what they were checking for. So they did find significant shifts, but it was lower. The results were lower Yeah. And the core thing that they were looking for, which was the emotional side of things, almost entirely fell out.

13:18they weren't able to replicate those results was interesting, 'cause they were like, "We wanna do this because of the effect that it's gonna have on emotional regulation." That wasn't the case, but the effect that they had, it had on inattention, hyperactivity, and general ADHD symptoms did remain, in this second study Yeah. And so yeah, it's definitely worth looking at being like, especially considering that this study, wasn't blinded at all to be like, this definitely shows that

13:54there is-- It's worth looking at this more yeah. Especially because, and I think this came up, a lot of the people who, said, and this is a very specific subset of people who no longer… Who want to take, different forms of medication, they said, they used to take medication but didn't anymore. So that was, 70, That was 84 people, said they used to take a, medication

14:27for ADHD but they didn't anymore, and the biggest reason for discontinuing it by far was the psychological side effects and the physical side effects. So there is a world where somebody has side effects to traditional ADHD medication and is searching for another alternative, and that, I think, is probably one of the groups of people that really want this research to continue Yeah, it's-- I think there are, especially finding effective non-stimulant,

15:03medications for people because there's so many people that have some sort of adverse effect with their stimulants. And also just to be clear for people, stimulants do work fine. I take stimulants. it's just, there are, there is a subset of people that need something different, and this is definitely a path that we can start exploring. again, don't do this on your own. Talk to your doctor. Yep, yep. Yeah, all the things. But, but an interesting conversation and, yeah, I'll be curious to see.

15:36The, the later research that came out didn't find a significant effect. and so that this might be a path that people, maybe went down and, found it doesn't have the effect when you really do the randomized control trials on it. maybe, if you liked this episode and you want us to look at the other papers that didn't have a significant effect, we could definitely do that and continue this conversation Yeah, I'd definitely look, be happy to look at more of these.

16:08I also did fall down a rabbit hole looking at, how, they try to blind, psychedelic studies because they do have such a h- high effect on people, even with the microdose. And one of the interesting findings I found was one of the, placebo drugs they give people is methylphenidate Okay. Huh Because it, purely from a like, "Oh, I feel something happening."

16:39they're like with, that kind of stimulant, they're like, "I have h- elevated heart rate, I'm more alert, I have this mild stimulation." And then they're like, that's what people often-- how people have that tell when they're taking a psychedelic, 'cause they're like, "Oh, I feel alive." And that's often what, people who don't have ADHD feel from something like Bethol Phenelzine. Huh, fascinating

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Back to the Basics: Bedtime Isn't Just Bedtime

    Nov 20, 202619 minVideo

    Hey Team! This week we're continuing our Back to Basics series by looking at one of the most important parts of managing our ADHD: getting enough sleep. And I know, telling you that sleep is important isn't exactly...

    Listen to the audio

    Credit the people on this episode

  2. ADHD Tools, Steps, and a Relaxed Conversation with Russ Jones Part 2

    Nov 16, 202651 minVideo

    Hey Team! This week we're picking back up with Russ Jones, a productivity coach for adults with ADHD and founder of ADHD Big Brother, an ADHD accountability community (he also hosts a podcast with the same name). This...

    Listen to the audio

    Credit the people on this episode

  3. Research Recap with Skye: ADHD Symptom Manifestation

    Nov 13, 202626 minVideo

    Welcome to Hacking Your ADHD. I'm your host, William Curb, and I have ADHD. On this podcast, I dig into the tools, tactics, and best practices to help you work with your ADHD brain. Today, I'm joined by Skye Waterson...

    Listen to the audio

    Credit the people on this episode

  4. Born not Built with Russ Jones

    Nov 9, 20261 hr 8 minVideo

    Hey Team! This week I'm talking with Russ Jones, a productivity coach for adults with ADHD and founder of ADHD Big Brother, an ADHD accountability community (he also hosts a podcast with the same name) - When Russ was...

    Listen to the audio

    Credit the people on this episode

  5. Everything Is Connected to Everything with Dr. Mel Houser

    Nov 2, 202646 minVideo

    Hey Team! This week I'm talking with Dr. Mel Houser, a family physician and founder of All Brains Belong, a nonprofit that brings together healthcare and community support for neurodivergent people. Dr. Houser is also...

    Listen to the audio

    Credit the people on this episode